NCT01469078View on ClinicalTrials.gov

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

November 30, 2012

Conditions
Chronic Kidney Disease
Interventions
DRUG

Monofer®

Single Bolus Injections

Sponsors

Lead Sponsor

Pharmacosmos A/S

Collaborators (1)

ClinSmart
All Listed Sponsors
collaborator

ClinSmart

INDUSTRY

lead

Pharmacosmos A/S

INDUSTRY